Source: Anti-Cancer Drugs. Unidade: FMRP
Subjects: ANTINEOPLÁSICOS, NEOPLASIAS MAMÁRIAS, QUIMIOTERAPIA ADJUVANTE, COMPLICAÇÕES NA GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Jurandyr Moreira de et al. Trastuzumab use during pregnancy: long-term survival after locally advanced breast cancer and long-term infant follow-up. Anti-Cancer Drugs, v. 27, n. 4, p. 369-372, 2016Tradução . . Disponível em: https://doi.org/10.1097/CAD.0000000000000344. Acesso em: 22 ago. 2024.APA
Andrade, J. M. de, Brito, L. G. O., Moisés, E. C. D., Amorim, A. C., Rapatoni, L., Carrara, H. H. A., & Tiezzi, D. G. (2016). Trastuzumab use during pregnancy: long-term survival after locally advanced breast cancer and long-term infant follow-up. Anti-Cancer Drugs, 27( 4), 369-372. doi:10.1097/CAD.0000000000000344NLM
Andrade JM de, Brito LGO, Moisés ECD, Amorim AC, Rapatoni L, Carrara HHA, Tiezzi DG. Trastuzumab use during pregnancy: long-term survival after locally advanced breast cancer and long-term infant follow-up [Internet]. Anti-Cancer Drugs. 2016 ; 27( 4): 369-372.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1097/CAD.0000000000000344Vancouver
Andrade JM de, Brito LGO, Moisés ECD, Amorim AC, Rapatoni L, Carrara HHA, Tiezzi DG. Trastuzumab use during pregnancy: long-term survival after locally advanced breast cancer and long-term infant follow-up [Internet]. Anti-Cancer Drugs. 2016 ; 27( 4): 369-372.[citado 2024 ago. 22 ] Available from: https://doi.org/10.1097/CAD.0000000000000344